A Double-Blind, Placebo-Controlled, Parallel Design Phase 3 Study to Assess the Efficacy, Safety, Tolerability, and Pattern of Use of SM-1 in Adult Subjects With a History of Transient Insomnia
Not yet recruiting
Phase of Trial: Phase III
Latest Information Update: 30 Nov 2018
At a glance
- Drugs Diphenhydramine/lorazepam/zolpidem (Primary)
- Indications Insomnia
- Focus Therapeutic Use
- Sponsors Sequential Medicine Ltd
- 21 Nov 2018 Planned End Date changed from 1 Jan 2019 to 1 Jan 2020.
- 21 Nov 2018 Planned primary completion date changed from 1 Jan 2019 to 1 Jan 2020.
- 21 Nov 2018 Planned initiation date changed from 1 Sep 2018 to 1 Jun 2019.